Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis

OBJECTIVES: Cannabis has been proposed as a potential treatment for Parkinson’s disease (PD) due to its neuroprotective benefits. However, there has been no rigorous review of preclinical studies to evaluate any potential treatment effect. This systematic review was undertaken to provide evidence in...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbi, Berzenn, Lee, Yunjoo, Hughes, Ian, Thorning, Sarah, Broadley, Simon A, Sabet, Arman, Heshmat, Saman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812814/
https://www.ncbi.nlm.nih.gov/pubmed/36618606
http://dx.doi.org/10.1136/bmjos-2022-100302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812814/
https://www.ncbi.nlm.nih.gov/pubmed/36618606
http://dx.doi.org/10.1136/bmjos-2022-100302

Ejemplares similares